Clinical Study Shows Velositol Doubles Power Of Protein For Significantly Improved Muscle Protein Synthesis
Purchase, NY (Feb. 28, 2017) – A new study published in Journal of the International Society of Sports Nutrition shows the combination of amylopectin and chromium in Nutrition 21’s patented ingredient Velositol doubles the muscle protein synthesis (MPS) rate compared to what was seen when using whey protein alone.
Nitrosigine®, Velositol®, nooLVL®, Chromax®, Lepidamax®, Zinmax®, and their associated logos are registered trademarks of Nutrition21, LLC. All third party trademarks are the property of their respective owners. Nutrition21, LLC's products are protected by a number of patents including, but not limited to: US Patent Nos. 6,809,115; 6,803,456; 7,576,132; 8,062,677; 8,933,022; 9,005,637; 9,028,879; 9,119,835; 9,421,170; 9,597,404; 9,675,702; 10,183,049; 10,245,325; and 10,363,222.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.